Estimating the national carbon footprint of inhalers in healthcare
Authors:
- 9 December 2022
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (5) , 2251-2253
Abstract
Background Metered dose inhalers (MDIs) contain greenhouse gases which have a disproportionate effect on the carbon footprint of healthcare. There are more environmentally friendly alternatives such as dry powder inhalers (DPIs) or soft mist inhalers (SMIs). Aims This study aims to approximate the carbon footprint of inhalers dispensed in Irish healthcare. Methods Health Market Research data was used to examine the number of inhalers sold in Ireland in 2019 via dispensing data from pharmacy IT systems. The carbon footprint per inhaler data was then used to calculate the total carbon footprint of each drug class, and an estimate for the total carbon footprint of inhalers sold in Ireland was generated. Results 4,427,287 inhalers were dispensed in Ireland in 2019 of which 2,608,433 (59%) were MDIs and 1,818,854 were DPIs/SMIs (41.1%). The total carbon equivalent of these inhalers was estimated to be 54,765 tCO2. MDIs account for 59% of inhaler units dispensed but account for 97% of inhaler-related carbon emissions. Conclusion Targeting inhaler prescribing offers the potential to significantly improve the carbon footprint of Irish healthcare. Establishing the current carbon footprint of the inhalers that are prescribed, dispensed, and disposed in Ireland is a necessary baseline to inform moving towards a net zero health service.Keywords
Funding Information
- Boehringer Ingelheim
This publication has 8 references indexed in Scilit:
- Deciphering patterns of respiratory medication use in Ireland to target interventions appropriately: a focus on COPDIrish Journal of Medical Science (1971 -), 2020
- Health care’s climate footprint: the health sector contribution and opportunities for actionEuropean Journal of Public Health, 2020
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in EnglandBMJ Open, 2019
- Reduced Environmental Impact of the Reusable Respimat® Soft Mist™ Inhaler Compared with Pressurised Metered-Dose InhalersAdvances in Therapy, 2019
- Sustainable Management of Natural Resources toward Sustainable Development GoalsResources, Conservation and Recycling, 2018
- The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public healthThe Lancet, 2018
- Retail sales of inhalation devices in European countries: So much for a global policyRespiratory Medicine, 2011
- Sub-optimal asthma control in teenagers in the midland region of IrelandIrish Journal of Medical Science (1971 -), 2011